$STI
Solidion Technology Inc.

2023 Q1 Form 10-Q Financial Statement

#000121390023041672 Filed on May 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $98.05K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $300.00
YoY Change
Gross Profit Margin 0.31%
Selling, General & Admin $1.038M $124.4K
YoY Change 734.44%
% of Gross Profit 345930.0%
Research & Development $760.5K
YoY Change
% of Gross Profit 253495.0%
Depreciation & Amortization $105.7K
YoY Change
% of Gross Profit 35224.0%
Operating Expenses $1.038M $124.4K
YoY Change 734.5%
Operating Profit -$1.742M
YoY Change
Interest Expense $1.361M $10.00K
YoY Change 13506.9%
% of Operating Profit
Other Income/Expense, Net $1.361M $8.660K
YoY Change 15612.4%
Pretax Income $322.9K -$112.0K
YoY Change -388.31%
Income Tax $275.2K
% Of Pretax Income 85.24%
Net Earnings $47.66K -$112.0K
YoY Change -142.55%
Net Earnings / Revenue 48.61%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share $0.00 -$39.55K
COMMON SHARES
Basic Shares Outstanding 69.80M shares
Diluted Shares Outstanding 69.80M shares

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.05K $1.268M
YoY Change -92.27%
Cash & Equivalents $98.05K $1.268M
Short-Term Investments
Other Short-Term Assets $189.3K $197.3K
YoY Change -4.03%
Inventory
Prepaid Expenses $189.3K
Receivables
Other Receivables
Total Short-Term Assets $287.4K $1.465M
YoY Change -80.39%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $130.2M $126.0M
YoY Change 3.33%
Other Assets $177.2K
YoY Change
Total Long-Term Assets $130.2M $126.2M
YoY Change 3.19%
TOTAL ASSETS
Total Short-Term Assets $287.4K $1.465M
Total Long-Term Assets $130.2M $126.2M
Total Assets $130.5M $127.6M
YoY Change 2.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $893.0K $510.5K
YoY Change 74.94%
Accrued Expenses $0.00 $5.000K
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $1.235M $125.3K
YoY Change 885.32%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.743M $656.5K
YoY Change 317.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.743M $656.5K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $7.066M $4.979M
YoY Change 41.91%
SHAREHOLDERS EQUITY
Retained Earnings -$6.110M
YoY Change
Common Stock $12.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.110M -$3.328M
YoY Change
Total Liabilities & Shareholders Equity $130.5M $127.6M
YoY Change 2.23%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $47.66K -$112.0K
YoY Change -142.55%
Depreciation, Depletion And Amortization $105.7K
YoY Change
Cash From Operating Activities -$522.3K -$2.570K
YoY Change 20223.42%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.035M -$126.0M
YoY Change -99.18%
Cash From Investing Activities -$1.035M -$126.0M
YoY Change -99.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.110M 127.2M
YoY Change -99.13%
NET CHANGE
Cash From Operating Activities -$522.3K -2.570K
Cash From Investing Activities -$1.035M -126.0M
Cash From Financing Activities $1.110M 127.2M
Net Change In Cash -$447.6K 1.268M
YoY Change -135.29%
FREE CASH FLOW
Cash From Operating Activities -$522.3K -$2.570K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41323
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1993879
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
13355 Noel Rd
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1100
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75240
CY2023Q1 dei City Area Code
CityAreaCode
(972)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
918-5120
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
true
CY2023Q1 us-gaap Cash
Cash
98053 usd
CY2022Q4 us-gaap Cash
Cash
545655 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
189318 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
215628 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
287371 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
761283 usd
CY2023Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
130174150 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
127782882 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35870 usd
CY2023Q1 us-gaap Assets
Assets
130461521 usd
CY2022Q4 us-gaap Assets
Assets
128580035 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
893007 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
439086 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
615145 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
339899 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
5000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
1235000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
125341 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2743152 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
909326 usd
CY2023Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4322500 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4322500 usd
CY2023Q1 us-gaap Liabilities
Liabilities
7065652 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5231826 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
129505753 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
127242983 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
12 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12 usd
CY2023Q1 nubi Common Stock Value1
CommonStockValue1
308 usd
CY2022Q4 nubi Common Stock Value1
CommonStockValue1
308 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6110204 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3895094 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-6109884 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3894774 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130461521 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128580035 usd
CY2023Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
CY2022Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
5000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1007788 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
119366 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1037788 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
124366 usd
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
1356319 usd
CY2022Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
8655 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
4375 usd
CY2022Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
3712 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1360694 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12367 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
322906 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-111999 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
275246 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
47660 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-111999 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3894774 usd
CY2023Q1 nubi Issuance Of Class B Common Stock To Sponsor
IssuanceOfClassBCommonStockToSponsor
-2262770 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
47660 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-6109884 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23570 usd
CY2022Q1 nubi Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
3755675 usd
CY2022Q1 nubi Proceeds From Private Warrants
ProceedsFromPrivateWarrants
5405000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-234654 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
776815 usd
CY2022Q1 nubi Issuance Of Class B Common Stock To Sponsor
IssuanceOfClassBCommonStockToSponsor
-12942102 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-111999 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3327695 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
47660 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-111999 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1356319 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
8655 usd
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3712 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-26310 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
197276 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-35870 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
177220 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
275246 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
448921 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
496288 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-522312 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2574 usd
CY2023Q1 us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
200051 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1235000 usd
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
125970000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1034949 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-125970000 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1109659 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
122265000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5405000 usd
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
429243 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1109659 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
127240757 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-447602 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1268183 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
545655 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98053 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1268183 usd
CY2022Q1 nubi Deferred Underwriters Compensation Charged To Temporary Equity In Connection With The Public Of
DeferredUnderwritersCompensationChargedToTemporaryEquityInConnectionWithThePublicOf
4322500 usd
CY2022Q1 nubi Class A Common Stock Measurement Adjustment
ClassACommonStockMeasurementAdjustment
12942102 usd
CY2022Q1 nubi Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
25000 usd
CY2022Q1 nubi Fair Value Of Representative Shares
FairValueOfRepresentativeShares
776815 usd
CY2022Q1 nubi Fair Value Of Overallotment Option
FairValueOfOverallotmentOption
19432 usd
CY2023Q1 nubi Class A Common Stock Redeemable Current Period Remeasurement Adjustment
ClassACommonStockRedeemableCurrentPeriodRemeasurementAdjustment
2262770 usd
CY2023Q1 us-gaap Common Unit Issued
CommonUnitIssued
70000000000000 shares
CY2023Q1 us-gaap Common Stock Issued Employee Stock Trust
CommonStockIssuedEmployeeStockTrust
22500000000000 usd
CY2023Q1 nubi Merger Agreement Description
MergerAgreementDescription
(i)5,000,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is thirty (30) days following the closing date of the Transactions (the “Closing Date”) until the second anniversary of the Closing Date, the VWAP of the shares of the Combined Company’s Class A common stock is greater than or equal to $12.50 per share (subject to any adjustment pursuant to the Merger Agreement); (ii)7,500,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the date that is forty-two (42) months following the Closing Date, the VWAP of the shares of Combined Company’s Class A common stock is greater than or equal to $15.00 per share (subject to any adjustment pursuant to the Merger Agreement); and   (iii)10,000,000 Earnout Shares if over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the fourth anniversary of the Closing Date, the VWAP of the shares of Combined Company’s Class A common stock is greater than or equal to $25.00 per share (subject to any adjustment pursuant to the Merger Agreement).  
CY2022Q1 nubi Gross Proceeds
GrossProceeds
405000 usd
CY2023Q1 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Debt Securities
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentDebtSecurities
0.80 pure
CY2023Q1 nubi Public Price Per Share
PublicPricePerShare
10.2
CY2023Q1 nubi Aggregate Share Percentage
AggregateSharePercentage
0.15 pure
CY2023Q1 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1 pure
CY2023Q1 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
1235000 usd
CY2023Q1 us-gaap Payments For Fees
PaymentsForFees
2470000 usd
CY2023Q1 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
1235000 usd
CY2023Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
100000 usd
CY2023Q1 nubi Reduction In Other Assets Per Shares
ReductionInOtherAssetsPerShares
10.2
CY2023Q1 us-gaap Sale Of Trust Assets To Pay Expenses
SaleOfTrustAssetsToPayExpenses
98053 usd
CY2023Q1 nubi Working Capital Deficit
WorkingCapitalDeficit
2455781 usd
CY2023Q1 nubi Risks And Uncertainties
RisksAndUncertainties
0.01 pure
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p>
CY2023Q1 us-gaap Payments To Invest In Decommissioning Fund
PaymentsToInvestInDecommissioningFund
130200000 usd
CY2022 us-gaap Payments To Invest In Decommissioning Fund
PaymentsToInvestInDecommissioningFund
127800000 usd
CY2023Q1 us-gaap Employee Stock Ownership Plan Esop Deferred Shares
EmployeeStockOwnershipPlanESOPDeferredShares
4322500 usd
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
776815 usd
CY2023Q1 nubi Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
129505753 usd
CY2023Q1 us-gaap Taxes Other
TaxesOther
100000 usd
CY2022Q4 nubi Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
127242983 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
2262770 usd
CY2023Q1 nubi Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
129505753 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.85 pure
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Preferred Stock Dividends Shares
PreferredStockDividendsShares
337500 shares
CY2023Q1 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
337500 shares
CY2022Q1 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
337500 shares
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2022Q1 nubi Purchase Of Underwriters Units
PurchaseOfUnderwritersUnits
1350000 shares
CY2022Q1 nubi Offering Price Per Unit
OfferingPricePerUnit
10
CY2022Q1 nubi Additional Gross Proceeds
AdditionalGrossProceeds
13500000 usd
CY2023Q1 us-gaap Sale Leaseback Transaction Gross Proceeds Investing Activities
SaleLeasebackTransactionGrossProceedsInvestingActivities
5000000 usd
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
11.5
CY2022Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
405000 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
405000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022Q1 nubi Aggregate To Founder Shares
AggregateToFounderShares
3162500 shares
CY2023Q1 nubi Percentage Of Issued And Outstanding
PercentageOfIssuedAndOutstanding
0.20 pure
CY2022 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
75000 shares
CY2023Q1 us-gaap Business Combination Control Obtained Description
BusinessCombinationControlObtainedDescription
The holders of the Founder Shares have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property. 
CY2021Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
300000 usd
CY2021Q3 nubi Aggregate Principal Amount Of Promissory Note
AggregatePrincipalAmountOfPromissoryNote
1000000 usd
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2023Q1 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
1235000 usd
CY2022 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
125341 usd
CY2023Q1 nubi Related Parties Paid
RelatedPartiesPaid
0 usd
CY2022 nubi Related Parties Paid
RelatedPartiesPaid
2841 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
10000 usd
CY2023Q1 us-gaap Related Party Tax Expense Due To Affiliates Deferred
RelatedPartyTaxExpenseDueToAffiliatesDeferred
30000 usd
CY2022 us-gaap Related Party Tax Expense Due To Affiliates Deferred
RelatedPartyTaxExpenseDueToAffiliatesDeferred
5000 usd
CY2023Q1 nubi Outstanding Related
OutstandingRelated
5000 usd
CY2022 nubi Outstanding Related
OutstandingRelated
5000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
1500000 usd
CY2023Q1 nubi Warrant Price
WarrantPrice
1
CY2023Q1 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
1650000 shares
CY2023Q1 nubi Aggregate Amount
AggregateAmount
4322500 usd
CY2022Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1350000 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
10 shares
CY2022Q1 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
13500000 usd
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
19432 usd
CY2023Q1 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
776815 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
123500 shares
CY2023Q1 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
3087500 shares
CY2023Q1 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.20 pure
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11580000 shares
CY2023Q1 us-gaap Preferred Stock Reason Why Security Is Not Redeemable
PreferredStockReasonWhySecurityIsNotRedeemable
Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00 — Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:    ● in whole and not in part;     ● at a price of $0.01 per Public Warrant;     ● upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and     ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.  
CY2023Q1 nubi Deferred Underwriters Compensation Charged To Temporary Equity In Connection With The Public Of
DeferredUnderwritersCompensationChargedToTemporaryEquityInConnectionWithThePublicOf
usd
CY2023Q1 nubi Class A Common Stock Measurement Adjustment
ClassACommonStockMeasurementAdjustment
usd
CY2023Q1 nubi Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
usd
CY2023Q1 nubi Fair Value Of Representative Shares
FairValueOfRepresentativeShares
usd
CY2023Q1 nubi Fair Value Of Overallotment Option
FairValueOfOverallotmentOption
usd
CY2022Q1 nubi Class A Common Stock Redeemable Current Period Remeasurement Adjustment
ClassACommonStockRedeemableCurrentPeriodRemeasurementAdjustment
usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001881551
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Nubia Brand International Corp.
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2022Q1 us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd

Files In Submission

Name View Source Status
f10q0323_nubiabrand_htm.xml Edgar Link completed
nubi-20230331_lab.xml Edgar Link unprocessable
0001213900-23-041672-index-headers.html Edgar Link pending
0001213900-23-041672-index.html Edgar Link pending
0001213900-23-041672.txt Edgar Link pending
0001213900-23-041672-xbrl.zip Edgar Link pending
f10q0323ex31-1_nubiabrand.htm Edgar Link pending
f10q0323ex31-2_nubiabrand.htm Edgar Link pending
f10q0323ex32-1_nubiabrand.htm Edgar Link pending
f10q0323ex32-2_nubiabrand.htm Edgar Link pending
f10q0323_nubiabrand.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nubi-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nubi-20230331_pre.xml Edgar Link unprocessable
nubi-20230331_cal.xml Edgar Link unprocessable
nubi-20230331_def.xml Edgar Link unprocessable